During the past decade, Centre Hospitalier de Montluçon conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Montluçon" #1 sponsor was "University Hospital, Clermont-Ferrand" with 5 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "Centre Jean Perrin" with 2 trials sponsored, "National Cancer Institute, France" with 1 trials sponsored and "UNICANCER" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Montluçon" #1 collaborator was "Jacques Lacarin Hospital Center" with 2 trials as a collaborator, "AUDIPOG" with 1 trials as a collaborator, "Bicetre Hospital" with 1 trials as a collaborator, "CH Annecy Genevois" with 1 trials as a collaborator and "CH d'Aurillac" with 1 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Montluçon" are "Breast Cancer" (3 trials), "Agitation,Psychomotor" (1 trials), "Arthroplasty Replacement, Knee" (1 trials), "Calprotectin" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Centre Hospitalier de Montluçon" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Montluçon" are "Drug" (6 trials), "Other" (2 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (3 trials), "Docetaxel" (2 trials), "cyclophosphamide" (2 trials), "ARBORea decision-making tool" (1 trials) and "Bilateral ultrasound examination 7+/- 2 after surgery" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Montluçon" are 6 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Montluçon". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Centre Hospitalier de Montluçon, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Montluçon, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".